Published in Clin Infect Dis on September 01, 1992
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol (1998) 7.01
Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol (1997) 5.86
Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev (1999) 5.84
In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol (1998) 5.13
Epidemiology of nosocomial fungal infections. Clin Microbiol Rev (1996) 5.03
Candida infections of medical devices. Clin Microbiol Rev (2004) 4.72
Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol (2006) 2.60
Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identification systems. J Clin Microbiol (1994) 2.54
Rapid identification of Candida species in blood cultures by a clinically useful PCR method. J Clin Microbiol (1997) 2.46
Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev (2004) 2.45
Rapid identification of Candida albicans by using Albicans ID and fluoroplate agar plates. J Clin Microbiol (1994) 2.05
Oral candidiasis. Postgrad Med J (2002) 2.02
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol (1999) 1.98
Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol (2002) 1.92
Treatment of murine Candida krusei or Candida glabrata infection with L-743,872. Antimicrob Agents Chemother (1997) 1.83
Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates. J Clin Microbiol (1996) 1.83
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine (2012) 1.77
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One (2011) 1.73
PCR identification of four medically important Candida species by using a single primer pair. J Clin Microbiol (1994) 1.72
Emerging infections in burns. Surg Infect (Larchmt) (2009) 1.57
Risk factors and outcomes of fungal ventricular-assist device infections. Clin Infect Dis (2010) 1.55
Development of a PCR-based line probe assay for identification of fungal pathogens. J Clin Microbiol (2000) 1.48
A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog (2011) 1.47
Candida endophthalmitis in non-neutropenic critically ill patients. Eur J Clin Microbiol Infect Dis (1996) 1.42
Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis (2003) 1.33
Prospective study of Candida species in patients at a comprehensive cancer center. Antimicrob Agents Chemother (2001) 1.33
Comparative genotyping of Candida albicans bloodstream and nonbloodstream isolates at a polymorphic microsatellite locus. J Clin Microbiol (2000) 1.27
Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis. J Clin Microbiol (1997) 1.27
Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis (2005) 1.26
An extracellular matrix-based mechanism of rapid neutrophil extracellular trap formation in response to Candida albicans. J Immunol (2013) 1.25
Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur J Clin Microbiol Infect Dis (1997) 1.25
Azole resistance in Candida. Eur J Clin Microbiol Infect Dis (1997) 1.23
Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings. Libyan J Med (2010) 1.23
Toll-like receptor 9-dependent activation of myeloid dendritic cells by Deoxynucleic acids from Candida albicans. Infect Immun (2009) 1.22
Random amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens. J Clin Microbiol (1998) 1.21
Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection. Eur J Clin Microbiol Infect Dis (2004) 1.20
Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis (2002) 1.19
Retracted Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol (2010) 1.16
Beta-1,2- and alpha-1,2-linked oligomannosides mediate adherence of Candida albicans blastospores to human enterocytes in vitro. Infect Immun (2003) 1.16
Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob Agents Chemother (2000) 1.16
Serum is more suitable than whole blood for diagnosis of systemic candidiasis by nested PCR. J Clin Microbiol (1999) 1.15
Effect of antifungal therapy timing on mortality in cancer patients with candidemia. Antimicrob Agents Chemother (2009) 1.14
Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response? Antimicrob Agents Chemother (1995) 1.12
PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies. J Clin Microbiol (1999) 1.12
Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol (2013) 1.10
Development of two species-specific fingerprinting probes for broad computer-assisted epidemiological studies of Candida tropicalis. J Clin Microbiol (1996) 1.08
Relevance of culturing Candida species from intravascular catheters. J Clin Microbiol (1995) 1.07
Detection and identification of Candida species in experimentally infected tissue and human blood by rRNA-specific fluorescent in situ hybridization. J Clin Microbiol (1997) 1.03
Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans. Lasers Med Sci (2007) 1.03
Prospects for the development of fungal vaccines. Clin Microbiol Rev (1997) 1.02
Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients. Support Care Cancer (2012) 0.98
Treatment of disseminated Torulopsis glabrata infection with DO870 and amphotericin B. Antimicrob Agents Chemother (1994) 0.98
Evaluation of bichro-latex albicans, a new method for rapid identification of Candida albicans. J Clin Microbiol (1997) 0.97
Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis (2008) 0.96
Genotyping of Candida albicans oral strains from healthy individuals by polymorphic microsatellite locus analysis. J Clin Microbiol (2003) 0.96
Fungal infections in transplant and oncology patients. Infect Dis Clin North Am (2010) 0.96
Role for endosomal and vacuolar GTPases in Candida albicans pathogenesis. Infect Immun (2009) 0.96
Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization. J Clin Microbiol (1999) 0.95
Fluconazole pharmacokinetics in burn patients. Antimicrob Agents Chemother (1998) 0.93
Performance of CHROMAGAR candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob (2003) 0.92
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group. Eur J Clin Microbiol Infect Dis (1997) 0.92
Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia. Eur J Clin Microbiol Infect Dis (2005) 0.92
Controlled comparison of BacT/ALERT FAN aerobic medium and BATEC fungal blood culture medium for detection of fungemia. J Clin Microbiol (2001) 0.91
Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B. Crit Care (2009) 0.91
A virtual infection model quantifies innate effector mechanisms and Candida albicans immune escape in human blood. PLoS Comput Biol (2014) 0.91
New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol (2002) 0.91
Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors. J Clin Microbiol (2000) 0.90
Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients. J Clin Microbiol (1998) 0.89
β-Defensin 1 plays a role in acute mucosal defense against Candida albicans. J Immunol (2015) 0.88
Emerging Issues in Nosocomial Fungal Infections. Curr Infect Dis Rep (1999) 0.88
Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease. J Clin Microbiol (1997) 0.86
High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study. Support Care Cancer (2004) 0.86
Incidence and predictors of invasive candidiasis associated with candidaemia in children. Mycoses (2011) 0.85
Risk factors for early invasive fungal disease in critically ill patients. Indian J Crit Care Med (2016) 0.85
Diorcinol D Exerts Fungicidal Action against Candida albicans through Cytoplasm Membrane Destruction and ROS Accumulation. PLoS One (2015) 0.84
Should all patients with candidemia be treated with antifungal agents? Clin Infect Dis (1992) 0.84
PCR melting profile (PCR MP)--a new tool for differentiation of Candida albicans strains. BMC Infect Dis (2009) 0.83
Invasive candidiasis in non-hematological patients. Mediterr J Hematol Infect Dis (2011) 0.83
Primary Candida guilliermondii Infection of the Knee in a Patient without Predisposing Factors. Case Rep Med (2012) 0.82
Prognostic factors for candidaemia in intensive care unit patients: a retrospective analysis. Singapore Med J (2016) 0.82
Fluconazole plasma concentration measurement by liquid chromatography for drug monitoring of burn patients. Clinics (Sao Paulo) (2010) 0.82
Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials. Eur J Clin Microbiol Infect Dis (2009) 0.81
Oral lactoferrin protects against experimental candidiasis in mice. J Appl Microbiol (2014) 0.81
Multilocus sequence typing of Candida tropicalis shows the presence of different clonal clusters and fluconazole susceptibility profiles in sequential isolates from candidemia patients in Sao Paulo, Brazil. J Clin Microbiol (2012) 0.80
Photodynamic antimicrobial chemotherapy (PACT) inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability. Lasers Med Sci (2013) 0.80
Effects of garlic extract treatment in normal and streptozotocin diabetic rats infected with Candida albicans. Indian J Clin Biochem (2010) 0.79
Therapeutic Approach to Candida Sepsis. Curr Infect Dis Rep (1999) 0.78
Outcomes, impact on management, and costs of fungal eye disease consults in a tertiary care setting. Ophthalmology (2014) 0.78
Duration of antifungal treatment and development of delayed complications in patients with candidaemia. Eur J Clin Microbiol Infect Dis (2003) 0.78
Urinary D-arabinitol/L-arabinitol levels in infants undergoing long-term antibiotic therapy. J Clin Microbiol (2005) 0.77
In vivo inhibitory effect on the biofilm formation of Candida albicans by liverwort derived riccardin D. PLoS One (2012) 0.77
Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. Oral Maxillofac Surg (2008) 0.77
The epidemiological profile of candidemia at an Indian trauma care center. J Lab Physicians (2014) 0.77
Fungal diagnostics. Cold Spring Harb Perspect Med (2014) 0.76
Advances in Candida detection platforms for clinical and point-of-care applications. Crit Rev Biotechnol (2016) 0.75
Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration to fluconazole. Adv Biomed Res (2016) 0.75
New challenges to the therapy of systemic fungal infections. Trans Am Clin Climatol Assoc (1996) 0.75
Susceptibility of Candida albicans and Candida dubliniensis to Photodynamic Therapy Using Four Dyes as the Photosensitizer. J Dent (Shiraz) (2016) 0.75
Usefulness of direct fluorescent in buffy coat in the diagnosis of Candida sepsis in neonates. J Perinatol (2016) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
MEASUREMENT OF CARDIAC OUTPUT IN MAN USING THE TECHNIQUE OF CATHETERIZATION OF THE RIGHT AURICLE OR VENTRICLE. J Clin Invest (1945) 20.31
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature (2005) 9.50
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet (2000) 8.79
Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob Control (2005) 8.56
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol (1999) 7.27
Antivirals for influenza in healthy adults: systematic review. Lancet (2006) 7.20
Variation in the susceptibility of strains of Staphylococcus aureus to oxacillin, cephalothin, and gentamicin. Antimicrob Agents Chemother (1976) 6.26
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol (1994) 5.34
Twenty five years of case finding and audit in a socially deprived community. BMJ (1991) 4.89
The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology (1995) 4.77
Classification of Histoplasma capsulatum isolates by restriction fragment polymorphisms. J Bacteriol (1986) 4.55
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med (1996) 4.43
Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). Proc Natl Acad Sci U S A (1972) 4.09
Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc Soc Exp Biol Med (1971) 4.02
Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med (1970) 3.74
Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell (2000) 3.54
Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol (1991) 3.38
Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse. Aliment Pharmacol Ther (2013) 3.32
Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole. Antimicrob Agents Chemother (1978) 3.29
Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother (1990) 3.26
The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96
Xkid, a chromokinesin required for chromosome alignment on the metaphase plate. Cell (2000) 2.90
Strategies in the treatment of systemic fungal infections. N Engl J Med (1980) 2.89
KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol (1989) 2.82
Evaluation of rooms with negative pressure ventilation used for respiratory isolation in seven midwestern hospitals. Infect Control Hosp Epidemiol (1993) 2.65
Australia's 1996 gun law reforms: faster falls in firearm deaths, firearm suicides, and a decade without mass shootings. Inj Prev (2006) 2.53
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Antimicrobial misuse in patients with positive blood cultures. Am J Med (1989) 2.45
Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med (1988) 2.44
Locus control region function and heterochromatin-induced position effect variegation. Science (1996) 2.42
Antibiotic synergism against Listeria monocytogenes. Antimicrob Agents Chemother (1972) 2.36
Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med (2000) 2.34
A structural basis for variegating position effects. Cell (1984) 2.31
Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum. Science (1972) 2.31
Socioeconomic differences in childhood consultation rates in general practice in England and Wales: prospective cohort study. BMJ (1999) 2.29
Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood (2001) 2.25
Potentiation of the antifungal effects of antibiotics by amphotericin B. Antimicrob Agents Chemother (1972) 2.24
Rapid radiometric method of testing susceptibility of mycobacteria and slow-growing fungi to antimicrobial agents. Antimicrob Agents Chemother (1974) 2.22
Lunar cycles and violent behaviour. Aust N Z J Psychiatry (1998) 2.21
Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med (1987) 2.20
Does colchicine work? The results of the first controlled study in acute gout. Aust N Z J Med (1987) 2.17
Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med (1983) 2.17
Antifungal agents useful in therapy of systemic fungal infections. Annu Rev Pharmacol Toxicol (1983) 2.11
Prevalence and time trends in obesity among adult West African populations: a meta-analysis. Obes Rev (2008) 2.11
In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeae. Antimicrob Agents Chemother (1979) 2.09
Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. J Thorac Cardiovasc Surg (1981) 2.08
Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis (1986) 2.08
Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N Engl J Med (1970) 2.05
A randomised controlled trial of the effect of the provision of free school milk on the growth of children. J Epidemiol Community Health (1980) 2.04
Repair of a mismatch is influenced by the base composition of the surrounding nucleotide sequence. Genetics (1987) 2.03
Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic. Chem Biol (1998) 2.02
Typing of Histoplasma capsulatum by restriction fragment length polymorphisms in a nuclear gene. J Clin Microbiol (1992) 2.02
Identification and molecular cloning of Moloney mouse sarcoma virus-specific sequences from uninfected mouse cells. Proc Natl Acad Sci U S A (1980) 1.98
An expert system for culture-based infection control surveillance. Proc Annu Symp Comput Appl Med Care (1993) 1.98
Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut (1997) 1.95
Interaction of plasma proteins and lipoproteins with amphotericin B. J Infect Dis (1984) 1.93
Involvement of Escherichia coli mismatch repair in DNA replication and recombination. Cold Spring Harb Symp Quant Biol (1984) 1.92
A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis (1997) 1.90
Adaptation to herbivory by the Tammar wallaby includes bacterial and glycoside hydrolase profiles different from other herbivores. Proc Natl Acad Sci U S A (2010) 1.89
Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev (2006) 1.89
Nonword repetition performance in school-age children with and without language impairment. J Speech Lang Hear Res (2000) 1.86
The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest (2000) 1.85
Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of Histoplasma capsulatum. Infect Immun (1989) 1.85
Using larvae in modern wound management. J Wound Care (1996) 1.84
External layers of Rickettsia prowazekii and Rickettsia rickettsii: occurrence of a slime layer. Infect Immun (1978) 1.82
Screen detected high blood pressure under 40: a general practice population followed up for 21 years. BMJ (1993) 1.82
Comparison of the separation of Candida albicans chromosome-sized DNA by pulsed-field gel electrophoresis techniques. Nucleic Acids Res (1989) 1.79
Amphotericin B: delivery systems. Antimicrob Agents Chemother (1990) 1.78
Irreversible block of the mycelial-to-yeast phase transition of Histoplasma capsulatum. Science (1986) 1.78
Mismatch repair of deaminated 5-methyl-cytosine. J Mol Biol (1987) 1.77
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther (1999) 1.76
Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics. J Infect Dis (1982) 1.76
Patients' attitude towards the use of a chaperone in breast examination. Ann R Coll Surg Engl (2008) 1.76
The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res (2001) 1.76
Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther (2000) 1.76
Pruritus and skin hydration during dialysis. Nephrol Dial Transplant (1996) 1.75
Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol (2000) 1.75
Automated system for identifying potential dosage problems at a large university hospital. Am J Health Syst Pharm (1997) 1.75
Increased oxygen consumption following activation of brain: theoretical footnotes using spectroscopic data from barrel cortex. Neuroimage (2001) 1.74
Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol (2000) 1.71
The effectiveness of preemployment drug screening in the prediction of employment outcome. J Occup Med (1992) 1.70
Variable expression of a yeast-phase-specific gene in Histoplasma capsulatum strains differing in thermotolerance and virulence. Infect Immun (1989) 1.70
Mortality of men in the Rhondda Fach 1950-80. Br J Ind Med (1985) 1.70
Classification of polyene antibiotics according to chemical structure and biological effects. Antimicrob Agents Chemother (1979) 1.69
Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells. EMBO J (1996) 1.68
Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene (2001) 1.68
Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68
GPs' perceptions of patient influence on prescribing. Fam Pract (1999) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Possible relationship of morphogenesis in pathogenic fungus, Histoplasma capsulatum, to heat shock response. Nature (1983) 1.67
Antifungal agents: recent developments. Annu Rev Microbiol (1977) 1.66
Total and specific IgE (house dust mite and intestinal helminths) in asthmatics and controls from Gondar, Ethiopia. Clin Exp Allergy (2000) 1.65
Correlation between pathogenicity and temperature sensitivity in different strains of Histoplasma capsulatum. J Clin Invest (1986) 1.65